Announcement
European Journal of Drug Metabolism and Pharmacokinetics invites submission of Original Research, Practical Application, Current Opinion and Review Articles on the topics of preclinical and clinical pharmacokinetics and pharmacodynamics.
Submit Now!

European Journal of Drug Metabolism and Pharmacokinetics promotes drug development by providing researchers essential information on preclinical and clinical pharmacokinetics & pharmacodynamics, including drug disposition, metabolism, transport and interactions, therapeutic drug monitoring, pharmacokinetic/pharmacodynamic relationship, bioavailability and biopharmacy.

As a hybrid journal, European Journal of Drug Metabolism and Pharmacokinetics does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘How to publish with us, including Open Access’ link below.

European Journal of Drug Metabolism and Pharmacokinetics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Journal information

Editor-in-Chief
  • Jasbir Singh
Publishing model
Hybrid. How to publish with us, including Open Access

Journal metrics

2.448 (2020)
Impact factor
2.204 (2020)
Five year impact factor
12 days
Submission to first decision (Median)
103,556 (2021)
Downloads

Latest articles

Journal updates

  • Digital Features

    European Journal of Drug Metabolism and Pharmacokinetics is able to host a range of digital features, with a number of options available to authors.

    Digital Features
View all updates

About this journal

Electronic ISSN
2107-0180
Print ISSN
0378-7966
Abstracted and indexed in
  1. BFI List
  2. BIOSIS
  3. Baidu
  4. Biological Abstracts
  5. CAB Abstracts
  6. CLOCKSS
  7. CNKI
  8. CNPIEC
  9. Chemical Abstracts Service (CAS)
  10. Dimensions
  11. EBSCO Discovery Service
  12. EMBASE
  13. Google Scholar
  14. Japanese Science and Technology Agency (JST)
  15. Journal Citation Reports/Science Edition
  16. Medline
  17. Meta
  18. Naver
  19. OCLC WorldCat Discovery Service
  20. Pathway Studio
  21. Portico
  22. ProQuest-ExLibris Primo
  23. ProQuest-ExLibris Summon
  24. Reaxys
  25. SCImago
  26. SCOPUS
  27. Science Citation Index Expanded (SCIE)
  28. TD Net Discovery Service
  29. UGC-CARE List (India)
  30. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG